1-24 of 25 Books

Neurobiology of DOPA as a neurotransmitter
By Yoshimi Misu
Developments in treatment for Parkinson's disease
Developments in treatment for Parkinson's disease
By George C. Cotzias
The Clinical Uses of L-Dopa
The Clinical Uses of L-Dopa
By G. Stern

The Treatment of Parkinsonism with L-Dopa
By Marks, John
Catechol- and indolamines in some endocrine cell systems
Catechol- and indolamines in some endocrine cell systems
By Hans Tjälve
Catecholamine turnover in central nervous system
Catecholamine turnover in central nervous system
By Torgny Persson
Catechol derivatives in the skin of young mice
Catechol derivatives in the skin of young mice
By Lennart Cegrell

The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons
By Robyn G. Young
Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease
Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease
By Stanley Fahn
Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10
Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10
By Brian Nowak-Thompson
Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance
Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance
By Judith Jourdain-Poitevien
Cardiovascular and renal effects of L-Dopa
Cardiovascular and renal effects of L-Dopa
By T. Budya Tjandramaga

Age-related dopamine-dependent disorders
By International Symposium on Age-Related Monoamine-Dependent Disorders and Their Modulation by Gene and Gender (1993 Tokyo, Japan)

Parkinson's disease
By Mark F. Lew,Cheryl H. Waters
Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones
Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones
By Abraham Pieter Morgenstern
Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans
Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans
By E. Koch
Current concepts in the treatment of Parkinsonism
Current concepts in the treatment of Parkinsonism
By